Expansion of human SCID-repopulating cells under hypoxic conditions

Journal of Clinical Investigation

Volumn 112, Issue 1, 2003, Pages 126-135

  Danet, Guénahel H ^a   Pan, Yi ^b   Luongo, Jennifer L ^a   Bonnet, Dominique A ^c   Simon, M Celeste ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD38 ANTIGEN; COMPLEMENTARY DNA; LACTIC ACID; RNA; VASCULOTROPIN; ADENOSINE DIPHOSPHATE RIBOSYL CYCLASE; CD38 PROTEIN, HUMAN; CD38 PROTEIN, MOUSE; HIF1A PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; TRANSCRIPTION FACTOR;

ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CELL SURVIVAL; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; HYPOXIA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCID MOUSE; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CELL CYCLE; CELL DIVISION; CELL HYPOXIA; IMMUNOLOGY; METABOLISM; MOUSE; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHYSIOLOGY;

ADP-RIBOSYL CYCLASE; ANIMALS; ANTIGENS, CD; ANTIGENS, CD34; ANTIGENS, CD38; BONE MARROW CELLS; CELL CYCLE; CELL DIVISION; CELL HYPOXIA; CELLS, CULTURED; HEMATOPOIETIC STEM CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED NOD; SEVERE COMBINED IMMUNODEFICIENCY; TRANSCRIPTION FACTORS;

EID: 85047692887     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI17669     Document Type: Article

References (64)

1. Harrison, J.S., Rameshwar, P., Chang, V., and Bandari, P. 2002. Oxygen saturation in the bone marrow of healthy volunteers. Blood 99:394.
2. Lichtman, M.A. 1981. The ultrastructure of the hemopoietic environment of the marrow: a review. Exp. Hematol. 9:391-410.
3. Cipolleschi, M.G., Dello Sbarba, P., and Olivotto, M. 1993. The role of hypoxia in the maintenance of hematopoietic stem cells. Blood. 82:2031-2037.
4. Ivanovic, Z., et al. 2000. Incubation of murine bone marrow cells in hypoxia ensures the maintenance of marrow-repopulating ability together with the expansion of committed progenitors. Br. J. Haematol. 108:424-429.
5. Adelman, D.M., Maltepe, E., and Simon, M.C. 1999. Multilineage embryonic hematopoiesis requires hypoxic ARNT activity. Genes Dev. 13:2478-2483.
6. Cipolleschi, M.G., et al. 1997. Severe hypoxia enhances the formation of erythroid bursts from human cord blood cells and the maintenance of BFU-E in vitro. Exp. Hematol. 25:1187-1194.
7. Quinlan, D.P., Jr., et al. 1998. Effect of hypoxia on the hematopoietic and immune modulator preprotachykinin-1. Arch. Surg. 133:1328-1334.
8. Ivanovic, Z., Dello Sbarba, P., Trimoreau, F., Faucher, J.L., and Praloran, V. 2000. Primitive human HPCs are better maintained and expanded in vitro at 1 percent oxygen than at 20 percent. Transfusion. 40:1482-1488.
9. Dick, J.E. 1996. Normal and leukemic human stem cells assayed in SCID mice. Semin. Immunol. 8:197-206.
10. Larochelle, A., et al. 1996. Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: implications for gene therapy. Nat. Med. 2:1329-1337.
11. Pflumio, F., et al. 1996. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. Blood. 88:3731-3740.
12. Bhatia, M., Wang, J.C.Y., Kapp, U., Bonnet, D., and Dick, J.E. 1997. Purification of primitive human hematopoietic cells capable of repopulating immune-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 94:5320-5325.
13. Wang, J.C., Doedens, M., and Dick, J.E. 1997. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood. 89:3919-3924.
14. Holyoake, T.L., Nicolini, F.E., and Eaves, C.J. 1999. Functional differences between transplantable human hematopoietic stem cells from fetal liver, cord blood, and adult marrow. Exp. Hematol. 27:1418-1427.
15. Danet, G.H., Lee, H.W., Luongo, J.L., Simon, M.C., and Bonnet, D.A. 2001. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion. Exp. Hematol. 29:1465-1473.
16. Bhatia, M., et al. 1997. Quantitative analysis reveals expansion of human hematopoietic repopulating cells after short-term ex vivo culture. J. Exp. Med. 186:619-624.
17. Conneally, E., Cashman, J., Petzer, A., and Eaves, C. 1997. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activty in nonobese diabetic-scid/scid mice. Proc. Natl. Acad. Sci. U. S. A. 94:9836-9841.
18. Piacibello, W., et al. 1999. Engraftment in nonobese diabetic severe combined immunodeficient mice of human CD34(+) cord blood cells after ex vivo expansion: evidence for the amplification and self-renewal of repopulating stem cells. Blood. 93:3736-3749.
19. Bhatia, M., et al. 1999. Bone morphogenetic proteins regulate the developmental program of human hematopoietic stem cells. J. Exp. Med. 189:1139-1148.
20. Ueda, T., et al. 2000. Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J. Clin. Invest. 105:1013-1021.
21. Bryder, D., and Jacobsen, S.E. 2000. Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro. Blood 96:1748-1755.
22. Kollet, O., et al. 2000. The plant lectin FRIL supports prolonged in vitro maintenance of quiescent human cord blood CD34(+)CD38 (-/low)/SCID repopulating stem cells. Exp. Hematol. 28:726-736.
23. Shih, C.C., et al. 2000. A secreted and LIF-mediated stromal cell-derived activity that promotes ex vivo expansion of human hematopoietic stem cells. Blood. 95:1957-1966.
24. Chute, J.P., et al. 2002. Ex vivo culture with human brain endothelial cells increases the SCID-repopulating capacity of adult human bone marrow. Blood. 100:4433-4439.
25. Harris, A.L. 2002. Hypoxia-a key regulatory factor in tumour growth. Nat. Rev. Cancer. 2:38-47.
26. Kaelin, W.G., Jr. 2002. How oxygen makes its presence felt. Genes Dev. 16:1441-1445.
27. 2-regulated gene expression. FASEB J. 16:1151-1162.
28. Semenza, G.L. 2001. HIF-1 and mechanisms of hypoxia sensing. Curr. Opin. Cell Biol. 13:167-171.
29. Ramirez-Bergeron, D.L., and Simon, M.C. 2001. Hypoxia-inducible factor and the development of stem cells of the cardiovascular system. Stem Cells. 19:279-286.
30. Jiang, B.H., Semenza, G.L., Bauer, C., and Marti, H.H. 1996. Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension. Am. J. Physiol. 271:C1172-C1180.
31. Semenza, G.L. 1998. Hypoxia-inducible factor 1 and the molecular physiology of oxygen homeostasis. J. Lab. Clin. Med. 131:207-214.
32. Tian, H., McKnight, S.L., and Russell, D.W. 1997. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 11:72-82.
33. Ema, M., et al. 1997. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc. Natl. Acad. Sci. U. S. A. 94:4273-4278.
34. Flamme, I., et al. 1997. HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1 alpha and developmentally expressed in blood vessels. Mech. Dev. 63:51-60.
35. Gu, Y.Z., Moran, S.M., Hogenesch, J.B., Wartman, L., and Bradfield, C.A. 1998. Molecular characterization and chromosomal localization of a third alpha-class hypoxia inducible factor subunit, HIF3alpha. Gene Expr. 7:205-213.
36. Guzman, M.L., et al. 2001. Nuclear factor-kappaB is constitutively activated in primitive human acute myelogenous leukemia cells. Blood. 98:2301-2307.
37. Hogge, D.E., Lansdorp, P.M., Reid, D., Gerhard, B., and Eaves, C.J. 1996. Enhanced detection, maintenance, and differentiation of primitive human hematopoietic cells in cultures containing murine fibroblasts engineered to produce human steel factor, interleukin-3, and granulocyte colony-stimulating factor. Blood. 88:3765-3773.
38. Sutherland, H.J., Eaves, C.J., Lansdorp, P.M., Thacker, J.D., and Hogge, D.E. 1991. Differential regulation of primitive human hematopoietic cells in long-term cultures maintained on genetically engineered murine stromal cells. Blood. 78:666-672.
39. Bonnet, D., Bhatia, M., Wang, J.C., Kapp, U., and Dick, J.E. 1999. Cytokine treatment or accessory cells are required to initiate engraftment of purified primitive human hematopoietic cells transplanted at limiting doses into NOD/SCID mice. Bone Marrow Transplant. 23:203-209.
40. Gerber, H.P., et al. 2002. VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism. Nature. 417:954-958.
41. Hattori, K., et al. 2001. Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells. J. Exp. Med. 193:1005-1014.
42. Liu, Y., Cox, S.R., Morita, T., and Kourembanas, S. 1995. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5′ enhancer. Circ. Res. 77:638-643.
43. Forsythe, J.A., et al. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol. 16:4604-4613.
44. Levy, A.P., Levy, N.S., Wegner, S., and Goldberg, M.A. 1995. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia. J. Biol. Chem. 270:13333-13340.
45. Wang, G.L., and Semenza, G.L. 1993. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J. Biol. Chem. 268:21513-21518.
46. Semenza, G.L., Roth, P.H., Fang, H.M., and Wang, G.L. 1994. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269:23757-23763.
47. Firth, J.D., Ebert, B.L., Pugh, C.W., and Ratcliffe, P.J. 1994. Oxygen-regulated control elements in the phosphoglycerate kinase 1 and lactate dehydrogenase A genes: similarities with the erythropoietin 3′ enhancer. Proc. Natl. Acad. Sci. U. S. A. 91:6496-6500.
48. Firth, J.D., Ebert, B.L., and Ratcliffe, P.J. 1995. Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements. J. Biol. Chem. 270:21021-21027.
49. Graeber, T.G., et al. 1996. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours. Nature. 379:88-91.
50. Schmaltz, C., Hardenbergh, P.H., Wells, A., and Fisher, D.E. 1998. Regulation of proliferation-survival decisions during tumor cell hypoxia. Mol. Cell. Biol. 18:2845-2854.
51. Iida, T., et al. 2002. Hypoxia-inducible factor-1alpha induces cell cycle arrest of endothelial cells. Genes Cells. 7:143-149.
52. Gardner, L.B., et al. 2001. Hypoxia inhibits G1/S transition through regulation of p27 expression. J. Biol. Chem. 276:7919-7926.
53. Wilpshaar, J., et al. 2000. Similar repopulating capacity of mitotically active and resting umbilical cord blood CD34(+) cells in NOD/SCID mice. Blood. 96:2100-2107.
54. Gothot, A., van der Loo, J.C., Clapp, D.W., and Srour, E.F. 1998. Cell cycle-related changes in repopulating capacity of human mobilized peripheral blood CD34(+) cells in non-obese diabetic/severe combined immune-deficient mice. Blood. 92:2641-2649.
55. Jaakkola, P., et al. 2001. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 292:468-472.
56. Ivan, M., et al. 2001. HIFalpha targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science. 292:464-468.
57. Cockman, M.E., et al. 2000. Hypoxia inducible factor-alpha binding and ubiquitylation by the von Hippel-Lindau tumor suppressor protein. J. Biol. Chem. 275:25733-23741.
58. Ohh, M., et al. 2000. Ubiquitination of hypoxia-inducible factor requires direct binding to the beta-domain of the von Hippel-Lindau protein. Nat. Cell Biol. 2:423-427.
59. Tanimoto, K., Makino, Y., Pereira, T., and Poellinger, L. 2000. Mechanism of regulation of the hypoxia-inducible factor-1 alpha by the von Hippel-Lindau tumor suppressor protein. EMBO J. 19:4298-4309.
60. Kamura, T., et al. 2000. Activation of HIF1alpha ubiquitination by a reconstituted von Hippet-Lindau (VHL) tumor suppressor complex. Proc. Natl. Acad. Sci. U. S. A. 97:10430-10435.
61. Ziegler, B.L., et al. 1999. KDR receptor: a key marker defining hematopoietic stem cells. Science. 285:1553-1558.
62. Hattori, K. et al. 2002. Placental growth factor reconstitutes hematopoiesis by recruiting VEGFR1(+) stem cells from bone-marrow microenvironment. Nat. Med. 8:841-849.
63. Oh, H., et al. 1999. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells. J. Biol. Chem. 274:15732-15739.
64. Hashiyama, M., et al. 1996. Predominant expression of a receptor tyrosine kinase, TIE, in hematopoietic stem cells and B cells. Blood. 87:93-101.